MM+M Podcast 6.14.22: Why Europe wants to close the orphan drug loophole

Preferential treatment for orphan drugs is very much in play overseas. Pricing guru Jack Mycka, VP in the PRMA division of Indegene, explains what potential European reforms could mean for pharma marketers in light of U.S. pressure to reform drug pricing. Check us out at: mmm-online.com

Follow us:

YouTube: @MMM-online

TikTok: @MMMnews

Instagram: @MMMnewsonline

Twitter/X: @MMMnews

LinkedIn: MM+M

To read more of the most timely, balanced and original reporting in
medical marketing, subscribe here.
Music: Opal 99 - Can't Go Out and Triple Scoop Music.

Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com
for information about our collection and use of personal data for
advertising.